ABRAHAM LIBREA: Open Payments
NPI 1578119954 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,262 in 71 payments from 22 companies in 2025. Trend: 2023 $1,414 · 2024 $1,284 · 2025 $1,262
Food & beverage: $1,262
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $287 |
| AstraZeneca Pharmaceuticals LP | 10 | $172 |
| Amgen Inc. | 7 | $117 |
| PFIZER INC. | 6 | $108 |
| Aimmune Therapeutics, Inc. | 4 | $61 |
| Lilly USA, LLC | 3 | $58 |
| Exact Sciences Corporation | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Abbott Laboratories | 2 | $38 |
Products named: VRAYLAR, AIRSUPRA, EVENITY, QULIPTA, ZENPEP, Cologuard Collection Kit, PREVNAR 20, LINZESS.
Industry payments across AZ — which companies pay providers there.
